Employment Verification for Spark Therapeutics.

About Spark Therapeutics

Spark Therapeutics is a Philadelphia-based gene therapy company that was founded in 2013. The company’s mission is to develop transformative gene therapies to treat genetic diseases. Spark Therapeutics has developed the first FDA-approved gene therapy for an inherited retinal disease, Luxturna, which was approved in late 2017. Spark Therapeutics has a pipeline of gene therapies for other genetic diseases including hemophilia A, hemophilia B, Huntington’s disease, and Pompe disease. The company also has partnerships and collaborations with various pharmaceutical companies and academic institutions. In 2019, Swiss pharmaceutical company Roche acquired Spark Therapeutics for $4.3 billion. Spark Therapeutics has sponsored and participated in various clinical trials to test the safety and efficacy of their gene therapies. The company has received numerous awards and recognitions for their groundbreaking work in gene therapy, including being named one of the 50 Smartest Companies by MIT Technology Review in 2016. Overall, Spark Therapeutics is a leading gene therapy company that is dedicated to developing life-changing treatments for genetic diseases.

The information on this page is not an endorsement of Truv’s services by Spark Therapeutics and is meant to be purely informational.

Verify Spark Therapeutics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.